Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2

The coronavirus disease 2019 (COVID‐19) pandemic has affected a large portion of the global population, both physically and mentally. Current evidence suggests that the rapidly evolving coronavirus subvariants risk rendering vaccines and antibodies ineffective due to their potential to evade existin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yiying, Mei, Husheng, Chen, Yisa, Griffin, James D., Liu, Qingsong, Weisberg, Ellen, Yang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/
https://www.ncbi.nlm.nih.gov/pubmed/37193304
http://dx.doi.org/10.1002/mco2.254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183156/
https://www.ncbi.nlm.nih.gov/pubmed/37193304
http://dx.doi.org/10.1002/mco2.254

Ejemplares similares